Through PTI NEW DELHI: Pharmaceutical company Abbott announced on Tuesday that it has launched a medical device in India that can be implanted in premature babies and newborns with congenital heart defects. The company launched Amplatzer Piccolo Occluder in India. This medical device can be implanted in the smallest babiesRead More →

First and only minimally invasive transcatheter treatment specifically approved for premature babies with a leaky duct Abbott, the global healthcare company, launched its Amplatzer Piccolo ™ Occluder in India, the world’s first medical device that can be implanted in the smallest babies (weighing as little as 700g) using a minimallyRead More →

In animal models, mothers deficient in iron had a significantly increased risk of having offspring with congenital heart disease (CHD). A team of researchers from the University of Oxford, funded by the British Heart Foundation, has identified a brand new risk factor for congenital heart disease (CHD). Using an animalRead More →